WCN26-6163 MARKERS OF IRON STORAGE AND CARDIOVASCULAR ADVERSE EVENTS IN PATIENTS UNDERGOING HEMODIALYSIS

Read full text Summarise with VIRAT
Authors: Hiroshi Nishi, Alan J. Fossa, Brian A. Bieber, Angelo Karaboyas, Roberto Pecoits‐Filho, Dhajanae Sylvertooth, Masaomi Nangaku
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The significance of aggressive intravenous iron supplementation for preventing major adverse cardiovascular events (MACE) in patients undergoing hemodialysis (HD) has been increasingly emphasized. However, how serum ferritin and transferrin saturation (TSAT), two fundamental iron status indicators, should be interpreted in terms of cardiovascular risk prediction remains unclear. The objective of this analysis was to investigate the association between these two markers and MACE including hospitalization due to heart failure.

Fields of Study & Subjects

Erythropoietin and Anemia Treatment Iron Metabolism and Disorders Dialysis and Renal Disease Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104844–104844
Publication date
25 March 2026
Language
EN